BlackRock’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213M | Buy |
|
|||||
|
2025
Q1 | $216M | Sell |
|
|||||
|
2024
Q4 | $240M | Buy |
|
|||||
|
2024
Q3 | $226M | Sell |
|
|||||
|
2024
Q2 | $176M | Sell |
|
|||||
|
2024
Q1 | $199M | Sell |
|
|||||
|
2023
Q4 | $194M | Sell |
|
|||||
|
2023
Q3 | $201M | Buy |
|
|||||
|
2023
Q2 | $202M | Buy |
|
|||||
|
2023
Q1 | $162M | Buy |
|
|||||
|
2022
Q4 | $268M | Buy |
|
|||||
|
2022
Q3 | $213M | Buy |
|
|||||
|
2022
Q2 | $194M | Buy |
|
|||||
|
2022
Q1 | $186M | Buy |
|
|||||
|
2021
Q4 | $159M | Buy |
|
|||||
|
2021
Q3 | $61.9M | Buy |
|
|||||
|
2021
Q2 | $36.8M | Buy |
|
|||||
|
2021
Q1 | $9.86M | Buy |
|
|||||
|
2020
Q4 | $10.3M | Buy |
|
|||||
|
2020
Q3 | $3.29M | Buy |
|